Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: biological insights and clinical advances
Christopher R. Reilly, Akiko Shimamura
Blood (2022) Vol. 141, Iss. 13, pp. 1513-1523
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Inherited Bone Marrow Failure Syndromes
Lorraine E. Canham, Jill L. O. de Jong
Elsevier eBooks (2024), pp. 51-94
Closed Access | Times Cited: 10
Inherited blood cancer predisposition through altered transcription elongation
Jiawei Zhao, Liam D. Cato, Uma P. Arora, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 642-658.e19
Open Access | Times Cited: 7
SURF2 is a MDM2 antagonist in triggering the nucleolar stress response
Sophie Tagnères, Paulo E. Santo, Julie Radermecker, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery?
Carmelo Gurnari, Simona Pagliuca, Jaroslaw P. Maciejewski
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 8, pp. 1389-1399
Closed Access | Times Cited: 10
A family case of Shwachman-Diamond syndrome in children with a rare genetic variant of the SBDS gene с.653G>A (p.Arg218Gln)
N. N. Grymova, V. Shadrina, Е. Г. Фурман
Perm Medical Journal (2025) Vol. 42, Iss. 1, pp. 130-138
Open Access
A germline ETV6 mutation disrupts hematopoiesis via de novo creation of a nuclear export signal
Michael McConville, Toby Thomas, Ryan Beckner, et al.
Science Advances (2025) Vol. 11, Iss. 16
Closed Access
European guidelines on treatment and supportive measures in chronic neutropenias: A consensus between the European Hematology Association and the EuNet‐INNOCHRON COST Action based on a systematic evidence review
Francesca Fioredda, Michail Spanoudakis, Julia Skokowa, et al.
HemaSphere (2025) Vol. 9, Iss. 4
Open Access
A Rare Case of Shwachman-Diamond Syndrome: Diagnostic Challenges and Management
Xinyi Xu, Yihui Huang
American Journal of Pediatrics (2025) Vol. 11, Iss. 2, pp. 58-62
Open Access
Discerning clinicopathological features of congenital neutropenia syndromes: an approach to diagnostically challenging differential diagnoses
Xenia Parisi, Jacob Bledsoe
Journal of Clinical Pathology (2024) Vol. 77, Iss. 9, pp. 586-604
Closed Access | Times Cited: 3
Integrated proteogenomic analysis for inherited bone marrow failure syndrome
Manabu Wakamatsu, Hideki Muramatsu, Hironori Sato, et al.
Leukemia (2024) Vol. 38, Iss. 6, pp. 1256-1265
Open Access | Times Cited: 2
CRISPR RNA-Guided Gene Editing and its Clinical Research Applications in Hematology with Focus on Inherited Germline Predisposition to Hematologic Malignancies
Rina Kansal
(2024)
Open Access | Times Cited: 2
Emerging genetic technologies informing personalized medicine in SDS and other inherited bone marrow failure disorders
Alyssa Cull, David G. Kent, Alan J. Warren
Blood (2024) Vol. 144, Iss. 9, pp. 931-939
Closed Access | Times Cited: 2
The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies
Rina Kansal
Genes (2024) Vol. 15, Iss. 7, pp. 863-863
Open Access | Times Cited: 2
Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy
Luke Maese, Marcin W. Włodarski, Sun Young Kim, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 19, pp. 4286-4295
Closed Access | Times Cited: 2
Needle in a haystack or elephant in the room? Identifying germline predisposition syndromes in the setting of a new myeloid malignancy diagnosis
Erica Reinig, Jeremy D. Rubinstein, Apoorva T. Patil, et al.
Leukemia (2023) Vol. 37, Iss. 8, pp. 1589-1599
Open Access | Times Cited: 4
Germline Predisposition to Myeloid Neoplasms
Ifeyinwa E. Obiorah, Kalpana Upadhyaya, Katherine R. Calvo
Clinics in Laboratory Medicine (2023) Vol. 43, Iss. 4, pp. 615-638
Closed Access | Times Cited: 4
Inherited bone marrow failure syndromes and germline predisposition to myeloid neoplasia: A practical approach for the pathologist
Jingwei Li, Jacob Bledsoe
Seminars in Diagnostic Pathology (2023) Vol. 40, Iss. 6, pp. 429-442
Closed Access | Times Cited: 4
Genomic testing for germline predisposition to hematologic malignancies
Sang Mee Hwang
Blood Research (2024) Vol. 59, Iss. 1
Open Access | Times Cited: 1
Azacitidine combined with venetoclax alleviates AML-MR with TP53 mutation in SDS: a case report and literature review
MA Cui-ping, Haiyan Lang, Yuhan Chen, et al.
Anti-Cancer Drugs (2024)
Closed Access | Times Cited: 1
Characteristic phenotypes of ADH5/ALDH2 deficiency during childhood
Mio Matsumoto, Momoko Oyake, Tomoyo Itonaga, et al.
European Journal of Medical Genetics (2024) Vol. 69, pp. 104939-104939
Open Access | Times Cited: 1
Germline Predisposition in Hematologic Malignancies
Rina Kansal
Elsevier eBooks (2024), pp. 1-38
Closed Access | Times Cited: 1
From Challenge to Opportunity: How Shwachman–Diamond Syndrome Became a Promising Target for Therapy Development
E Hars, Lisa J. McReynolds
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 6, pp. 1377-1380
Open Access | Times Cited: 1
Molecular pathophysiology of germline mutations in acute myeloid leukemia
Yasunobu Nagata
International Journal of Hematology (2024) Vol. 120, Iss. 4, pp. 417-426
Closed Access | Times Cited: 1
Minimal intensity conditioning strategies for bone marrow failure: is it time for “preventative” transplants?
Suneet Agarwal
Hematology (2023) Vol. 2023, Iss. 1, pp. 135-140
Closed Access | Times Cited: 3
Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment
Mengxin Wang, Stephen Vulcano, Changlu Xu, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 14, Iss. 3, pp. 308-320
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top